Skin cancer treatment costs skyrocket over past decade

The average annual cost for skin cancer treatment more than doubled from 2002 to 2011, a report from the Centers for Disease Control and Prevention found. From 2002 to 2006, the average annual skin...

Field of Interest: Dermatology
Type: News Item

Oral curcumin shown effective in psoriasis

AMSTERDAM – Oral curcumin proved safe and effective as adjunctive therapy in patients on topical corticosteroids for mild to moderate psoriasis vulgaris in a 12-week, randomized, placebo-controlled...

Field of Interest: Dermatology
Type: News Item

VIDEO: A practical protocol for monitoring discoid lupus

NEWPORT BEACH, CALIF.– Patients with discoid lupus should be checked routinely for systemic disease, but complete autoantibody studies aren’t necessary for those patients with a prior work-up and a...

Field of Interest: Dermatology
Type: News Item

Select biologics for dose escalation in psoriasis

SONOMA, CALIF.– Data support dosage escalation or intensification for patients who don’t respond to biologic therapy for psoriasis, but only for three of the four biologic agents available in the...

Field of Interest: Dermatology
Type: News Item

Secukinumab showed sustained efficacy in psoriasis

AMSTERDAM – The investigational biologic agent secukinumab continued to show strong efficacy through 52 weeks of treatment in a new secondary analysis of the pivotal phase III ERASURE trial. For...

Field of Interest: Dermatology
Type: News Item

In psoriasis, is pushing for PASI 90 really worthwhile?

AMSTERDAM – Does pushing for a PASI 90 response instead of settling for a PASI 75 matter to patients being treated for moderate-to-severe chronic plaque psoriasis? You bet it does, Dr. Mark G....

Field of Interest: Dermatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.